NCT02434744 Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT02429258 Effect of Dapagliflozin on 24-hour Blood Glucose in T2DM Patients Inadequately Controlled With Either Metformin Or Insulin Status COMPLETED Phase PHASE4
NCT02417090 Late Metabolic Effects of Metformin Therapy in Gestational Diabetes Status COMPLETED Phase N/A
NCT02411825 Multiple Ascending Dose Study in Healthy Male Subjects and Overweight to Obese Male and Female Type 2 Diabetes Mellitus (T2DM) Patients Status COMPLETED Phase PHASE1
NCT02409238 Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study Status TERMINATED Phase PHASE4
NCT02407899 Protective Effects of Saxagliptin (And Vitamin D3) on β Cell Function in Adult-onset Latent Autoimmune Diabetes Status COMPLETED Phase PHASE4
NCT02402348 Pilot Study of Metformin in HNSCC to Investigate the Effects of MF, Tumor Genotype and MF-genotype Interactions, on Tumor Metabolism and Anoikis Status TERMINATED Phase EARLY_PHASE1
NCT02394652 The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial Status COMPLETED Phase PHASE2
NCT02393573 Attenuating The Post-Operative Insulin Resistance And Promoting Protein Anabolism Status TERMINATED Phase NA
NCT02366377 The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus Patients Status UNKNOWN Phase PHASE1
NCT02365597 An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02360059 Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer Status TERMINATED Phase PHASE2
NCT02343926 Phase 3 Study to Compare the Efficacy and Safety of Gemigliptin and Vildagliptin as Add-on Therapy to Metformin in People With Type 2 Diabetes Inadequately Controlled With Metformin Status COMPLETED Phase PHASE3
NCT02342925 A Study of the Effect of RG1662 on Metformin in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02338921 Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy Status COMPLETED Phase PHASE4